CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Takara Bio Inc Company Snapshot
Takara Bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takara Bio Inc with three other companies in this sector in Japan: Sosei Group Corporation (2017 sales of 18.90 billion Japanese Yen [US$169.92 million] ), Morishita Jintan Co., Ltd. (10.97 billion Japanese Yen [US$98.59 million] ), and Shin Nippon Biomedical Laboratories Ltd (17.24 billion Japanese Yen [US$155.03 million] ).

Sales Analysis. Takara Bio Inc reported sales of ¥29.38 billion (US$264.08 million) for the fiscal year ending March of 2017. This represents a decrease of 1.2% versus 2016, when the company's sales were ¥29.73 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Takara Bio Inc
  Stock Performance Chart for Takara Bio Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 1,545.00
(Figures in Japanese Yen)
1 Week -3.0%   13 Weeks -1.5%  
4 Weeks -0.1%   52 Weeks 9.1%  
 
Takara Bio Inc Key Data:
  Ticker: 4974 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 29,375,000,000
(Year Ending Jan 2018).
Employees: 1,273
  Currency: Japanese Yen Market Cap: 186,042,102,000
  Fiscal Yr Ends: March Shares Outstanding: 120,415,600
  Share Type: Common Closely Held Shares: 73,350,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.